TWD 37.1
(-2.5%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.56 Billion TWD | 38.7% |
2022 | 1.84 Billion TWD | 4.75% |
2021 | 1.76 Billion TWD | 1.15% |
2020 | 1.74 Billion TWD | 11.53% |
2019 | 1.56 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 2.6 Billion TWD | 1.55% |
2024 Q2 | 2.6 Billion TWD | 0.0% |
2023 Q2 | 2.56 Billion TWD | 0.0% |
2023 FY | 2.56 Billion TWD | 38.7% |
2023 Q4 | 2.56 Billion TWD | 0.0% |
2023 Q3 | 2.56 Billion TWD | -0.19% |
2023 Q1 | 2.56 Billion TWD | 38.97% |
2022 Q4 | 1.84 Billion TWD | 0.0% |
2022 Q3 | 1.84 Billion TWD | 0.0% |
2022 FY | 1.84 Billion TWD | 4.75% |
2021 FY | 1.76 Billion TWD | 1.15% |
2020 FY | 1.74 Billion TWD | 11.53% |
2019 FY | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | -23.27% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -118.03% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -111.131% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 74.049% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 78.15% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 76.297% |
Center Laboratories, Inc. | 27 Billion TWD | 90.509% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -291.825% |
InnoPharmax Inc. | 524.19 Million TWD | -388.877% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -28.587% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -62.469% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -41.378% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -37.671% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 15.624% |
UniPharma Co., Ltd. | 350.07 Million TWD | -632.038% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | -15.51% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -163.323% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -219.625% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -484.985% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -372.253% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -83.067% |